You are here: Industry Insights > pharma news

News List

Weekly Pharma News Review | PharmaSources.com (1114-1118) PharmaSources.com
November 21, 2022
The news review of this week is from November 14 to 18, covering a total of 23 pieces of information in 3 sections, i.e., drug review, R&D, and business.
Weekly Pharma News Review | PharmaSources.com (1107-1111) PharmaSources.com
November 14, 2022
The news review of this week is from November 7 to 11, covering a total of 26 pieces of information in 3 sections, i.e., drug review, R&D, and business.
Weekly Pharma News Review | PharmaSources.com (1031-1104) PharmaSources.com
November 08, 2022
The news review of this week is from October 31 to November 4, covering a total of 25 pieces of information in 3 sections, i.e., drug review, R&D, and business.
Weekly Pharma News Review | PharmaSources.com (1024-1028) PharmaSources.com
October 31, 2022
The news review of this week is from October 24 to 28, covering a total of 23 pieces of information in 4 sections, i.e., drug review, R&D, business and listing.
Weekly Pharma News Review | PharmaSources.com (1017-1021) PharmaSources.com
October 24, 2022
The news review of this week is from October 17 to 21, covering a total of 21 pieces of information in 3 sections, i.e., drug review, R&D, and listing.
Weekly Pharma News Review | PharmaSources.com (1008-1014) PharmaSources.com
October 18, 2022
The most exciting thing for the industry is the first-in-class drug, Dorzagliatin Tablets, which is independently researched and developed by Hua Medicine was approved for marketing, becoming the first approved new drug for GKA diabetes in the world.
Weekly Pharma News Review | PharmaSources.com (0926-0930) PharmaSources.com
October 08, 2022
The news reviewed this week is from September 26 to 30, covering a total of 26 pieces of information in 4 sections, i.e. drug review, R&D, business and policy.
Weekly Pharma News Review | PharmaSources.com (0919-0923) PharmaSources.com
September 26, 2022
The news reviewed this week is from September 19 to 23, covering a total of 25 pieces of information in 4 sections, i.e. drug review, R&D, and business and listing.
Weekly Pharma News Review | PharmaSources.com (0912-0916) PharmaSources.com
September 20, 2022
The news reviewed this week is from September 12 to 16, covering a total of 26 pieces of information in 3 sections, i.e., drug review, R&D, and business.
Weekly Pharma News Review | PharmaSources.com (0905-0909) PharmaSources.com
September 14, 2022
The news review of this week is from September 5 to 9, covering a total of 25 pieces of information in 3 sections, i.e., drug review, R&D, and business.

Previous page 1 2 Next page